Highlights

  • Mirion reports quarterly EPS below consensus; revenue misses expectations.
  • FY2026 guidance updated following year-on-year revenue growth.
  • Recent analyst actions and valuation metrics outlined.

Mirion Technologies Inc. (NYSE:MIR) drew market attention after its latest quarterly results showed earnings and revenue coming in below consensus estimates, even as year-on-year sales growth remained positive and full-year guidance was updated. The company reported earnings per share of USD 0.15 for the quarter, below the consensus estimate of USD 0.17 by USD 0.02. Revenue for the period reached USD 277.40 million, compared with expectations of USD 281.17 million. The company recorded a net margin of 2.93% and a return on equity of 7.09%. Revenue rose 9.1% year over year, while the comparable quarter last year reported EPS of USD 0.17. The company updated its FY2026 guidance to EPS of 0.500–0.570.

Valuation and trading ranges
As of February 10, 2026, Mirion Technologies had a market capitalisation of USD 5.96 billion, a price-to-earnings ratio of 213.56, and a beta of 0.97. Balance sheet indicators included a debt-to-equity ratio of 0.63, a quick ratio of 4.32, and a current ratio of 4.83. The stock’s 52-week range spans USD 12.00 to USD 30.28, with 50-day and 200-day moving averages at USD 24.89 and USD 23.98, respectively.

Analyst Ratings Changes
Recent research actions included JPMorgan Chase & Co. raising its price target to USD 34.00 from USD 28.00 with an overweight rating; Evercore initiating coverage with an outperform rating and a USD 29.00 target; Morgan Stanley assuming coverage with an equal weight rating and a USD 29.00 target; and Citigroup lowering its target to USD 33.00 from USD 35.00 while maintaining a buy rating. Across coverage tracked by MarketBeat, seven analysts rate the stock buy and two rate it hold, with an average rating of “Moderate Buy” and a consensus target of USD 28.38.

Business Overview

Mirion Technologies provides radiation detection, measurement, and monitoring solutions across nuclear power, oil and gas, defense and homeland security, and medical imaging and diagnostics. Its portfolio includes instrumentation, software, and services covering personal and environmental dosimetry, area monitoring, digital imaging detectors, and solutions for decommissioning and environmental remediation. The company traces its roots to several established radiation measurement businesses, including the former Canberra nuclear instrumentation division, and listed on the New York Stock Exchange in 2023 following private equity backing.

Latest closing price (as of February 10, 2026): Mirion Technologies Inc. (NYSE: MIR) closed at USD 23.44, down USD 0.65 (-2.70%).